Laurion Capital Management LP Longboard Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.0 - $27.03 $40,902 - $65,034	-2,406 Reduced 3.51%	66,149 $1.79 Million
Q1 2024 May 15, 2024	BUY	$18.89 - $26.06 $881,124 - $1.22 Million	46,645 Added 212.89%	68,555 $1.48 Million
Q4 2023 Feb 14, 2024	SELL	$3.68 - $6.5 $33,149 - $58,552	-9,008 Reduced 29.14%	21,910 $132,000
Q1 2023 May 15, 2023	BUY	$3.84 - $5.96 $38,400 - $59,600	10,000 Added 47.81%	30,918 $123,000
Q2 2021 Aug 13, 2021	SELL	$7.95 - $17.3 $27,681 - $60,238	-3,482 Reduced 14.27%	20,918 $191,000
Q1 2021 May 14, 2021	BUY	$16.0 - $16.89 $390,400 - $412,116	24,400 New	24,400 $398,000

126

34.9M

28.9K

13.9K

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $815M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.